Seeking Alpha

Edwards Life Sciences (EW +11.3%) jumps after its Q1 easily beats estimates on strong sales...

Edwards Life Sciences (EW +11.3%) jumps after its Q1 easily beats estimates on strong sales growth of Sapien, its catheter-delivered heart valve. However, the company is lowering its FY12 sales estimates for the valves by $30M on an expected one-quarter delay in U.S. approval for patients at high risk for surgery.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs